A tighter archive for life-science signals.
Search once, then narrow by source or topic.
<a href="https://www.fiercebiotech.com/biotech/letter-makary-biotech-ceos-push-fda-stability-and-say-volatility-threatens-us-innovation" hreflang="en">In letter to Makary, biotech CEOs push for FDA stability and say volatility threatens US innovation</a>
Hundreds of industry leaders have signed a letter to FDA Director Marty Makary, M.D., about the importance of having a predictable regulatory agency, citing a survey in...
Illumina CEO Jacob Thaysen: Anchoring “In China, For China” to Drive a New Chapter in China’s Healthcare Through Technology - Caixin Global
Illumina CEO Jacob Thaysen: Anchoring “In China, For China” to Drive a New Chapter in China’s Healthcare Through Technology Caixin Global
Insider Selling: Agilent Technologies (NYSE:A) CEO Sells 911 Shares of Stock - MarketBeat
Insider Selling: Agilent Technologies (NYSE:A) CEO Sells 911 Shares of Stock MarketBeat
Jeff Bluestone, Stephen Dilly talk CEO handoff, what’s next for Sonoma; Scott Gottlieb's next move
Endpoints News sat down with Jeff Bluestone and Stephen Dilly after Sonoma Biotherapeutics announced earlier this week that Bluestone was stepping down from his CEO rol...
'Hopeful' We'll Find Long-term Solution On China: Illumina CEO - Bloomberg.com
'Hopeful' We'll Find Long-term Solution On China: Illumina CEO Bloomberg.com
Illumina sales flat in Q3 amid China headwinds as CEO remains 'in dialogue' with agencies - Fierce Biotech
Illumina sales flat in Q3 amid China headwinds as CEO remains 'in dialogue' with agencies Fierce Biotech
Roche in ongoing discussions with US government over drug pricing, CEO says - Pharmaceutical Technology
Roche in ongoing discussions with US government over drug pricing, CEO says Pharmaceutical Technology